NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Impact of Spiroergometer Parameters as Diagnostic Marker of Cardiac Ischemia in Pts. With Stable Angina Compared to FFR.
Impact of Spiroergometer Parameters as Diagnostic Marker of Cardiac Ischemia in Pts. With Stable Angina Compared to FFR.
CompletedN/A
Sponsor: Jena University Hospital
Conditions: Stable Angina
Interventions: ergospirometer test
Countries: Germany
In Patients with stable Angina pectoris CCS 1-3 exercise testing for ischemia detection is widely used despite the known limitations. Measurement of the FFR is invasive but gold standard for Ischemia detection. Adding of parameters of spiroergometer might help to improve diagnostic accuracy of non invasive exercise testing. Therefore the trial is evaluating diagnostic accuracy of spiroergometric parameters compared to invasive FFR measurement.
Eligibility overview
Sex: ALL
Age: 18 Years to —
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion Criteria: * stable Angina (CCS \>1-3) with suspected CAD or * dyspnoea at exertion NYHA \>2 or * signs of ischemia within SPECT or exercise electrocardiography * willingness to participate in the trial Exclusion Criteria: * Unstable angina or myocardial infarction within the last 2 weeks * inability to perform bicycle exercise test * significant valvular disease * HOCM * av- block \>I degree * asthma bronchiales
Locations (1)
- Jena, Germany